Cytogenetic analysis in patients with primary myelodysplastic syndromes in leukaemic transformation: A report on 94 cases
Hematology and Cell Therapy · 1996
DOI: 10.1007/s00282-996-0177-7 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Hematology and Cell Therapy, 1996. Die Arbeit wurde bisher 22-mal zitiert (Crossref).
Abstract (Originalsprache)
A series of 94 patients presenting primary refractory anaemia with excess of blasts in transformation or acute myeloid leukaemia occurring after a myelodysplastic stage was submitted to retrospective cytogenetic analysis by the Groupe Français de Cytogénétique Hématologique. The aim of this collaborative study was to analyze the patterns of chromosome abnormalities appearing in primary myelodysplastic syndromes (MDS) in leukaemic transformation. As previously described in the literature, the most common chromosome aberrations involved del(5q), -7, +8, 17, 11, 12p and del(20q), while abnormalities of chromosome 17p were more frequently detected during the leukaemic transformation of MDS. The translocations t(2;3) (p22-23;q26-28) and whole arm t(17;18) were confirmed to be nonrandom events in these myeloid disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Zitieren
APA
(1996). Cytogenetic analysis in patients with primary myelodysplastic syndromes in leukaemic transformation: A report on 94 cases. Hematology and Cell Therapy. https://doi.org/10.1007/s00282-996-0177-7
Vancouver
Cytogenetic analysis in patients with primary myelodysplastic syndromes in leukaemic transformation: A report on 94 cases. Hematology and Cell Therapy. 1996. doi:10.1007/s00282-996-0177-7
BibTeX
@article{euvimed1996,
title = {Cytogenetic analysis in patients with primary myelodysplastic syndromes in leukaemic transformation: A report on 94 cases},
journal = {Hematology and Cell Therapy},
year = {1996},
doi = {10.1007/s00282-996-0177-7}
}
EUVIMED